Related Experiment Video
Updated: Feb 18, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
De novo food allergy in pediatric liver transplantation recipients
Ratchaneewan Sinitkul1, Wiparat Manuyakorn1, Wasu Kamchaisatian1
1Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Insights
Food allergy (FA) is common after pediatric liver transplants (LT), affecting over half of recipients. Younger age at transplant, family history of atopy, and Epstein-Barr virus (EBV) viremia increase FA risk.
Area of Science:
- Pediatric Gastroenterology
- Transplant Immunology
- Allergy and Immunology
Background:
- The prevalence of food allergy (FA) is rising in children who have undergone liver transplantation (LT).
- Limited data exists on the clinical course and outcomes of de novo FA post-LT.
Purpose of the Study:
- To determine the prevalence of de novo food allergy in pediatric liver transplant recipients.
- To identify risk factors associated with developing de novo FA post-LT.
- To describe the natural history of de novo FA in this population.
Main Methods:
- Retrospective cohort study of pediatric LT recipients (Jan 2001 - Dec 2014).
- De novo FA diagnosed by post-LT symptoms, improvement with elimination diets, and confirmed by re-challenge, sensitization, or eosinophilia.
- Analysis of medical records to identify risk factors and clinical characteristics.
Main Results:
- Over half (54.3%) of 46 pediatric LT recipients developed de novo FA at a median of 12.2 months post-transplant.
- Confirmed FA occurred in 39.1%, with gastrointestinal symptoms being most common, followed by skin reactions and anaphylaxis.
- Risk factors included age <2 years at LT (HR 2.62), family history of atopy (HR 5.67), and Epstein-Barr virus (EBV) viremia (HR 2.39).
Conclusions:
- De novo food allergy is a significant concern in pediatric liver transplant recipients.
- Early age at transplant (<2 years), family history of atopy, and EBV viremia are key risk factors for developing FA.
- Tolerance development over 3 years appears similar to the general population.
Background:
Food allergy (FA) prevalence is increasing in pediatric liver transplantation (LT). However, the clinical course is still limited.
Objective:
This retrospective cohort study aimed to identify the prevalence, risk factors, and the natural history of de novo FA in children post LT.
Methods:
Medical records of pediatric LT recipients from Jan 2001 - Dec 2014 were reviewed. De novo FA was diagnosed by symptoms after exposure to culprit food occurring after LT, and improvement after diet elimination. FA was confirmed if reproduced symptoms after re-challenge or documented sensitization or indicated gastrointestinal eosinophilia.
Results:
Among 46 post LT children, 54.3% developed de novo FA at a median time of 12.2 months [Interquartile range (IQR) 6.2, 21.3 months] post LT. The confirmed FA was 39.1%. Gastrointestinal symptom was the most common manifestation followed by skin, anaphylaxis, and others. Culprit foods were cow's milk, shellfish, egg, wheat, soybean, peanut, coconut, fish and monosodium glutamate. The risk factors of FA were transplantation during age below 2 years [hazard ratio (HR), 2.62; 95% confidence interval (CI), 1.04 - 6.59; p = 0.03), atopic history in family (HR, 5.67; 95% CI, 1.33 - 24.12; p = 0.01), and Epstein-Barr (EBV) viremia (HR, 2.39; 95% CI, 1.02 - 5.63; p = 0.04).
Conclusions:
de novo FA in pediatric LT is not uncommon. Age at LT younger than 2 years, family history of atopy, and EBV viremia are associated with developing FA. Development of tolerance after elimination culprit diets for 3 years is similar to general population.
More Related Videos
Related Concept Videos
Drug Toxicity: Allergic Reactions
Kidney Transplant II: Surgical Procedure
Allergic Reactions
Allergic Reactions: Anaphylaxis
Kidney Transplant I: Introduction
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

